215 related articles for article (PubMed ID: 12011898)
1. Medical, social, and legal implications of treating nausea and vomiting of pregnancy.
Brent R
Am J Obstet Gynecol; 2002 May; 186(5 Suppl Understanding):S262-6. PubMed ID: 12011898
[TBL] [Abstract][Full Text] [Related]
2. Bendectin and birth defects. II: Ecological analyses.
Kutcher JS; Engle A; Firth J; Lamm SH
Birth Defects Res A Clin Mol Teratol; 2003 Feb; 67(2):88-97. PubMed ID: 12769504
[TBL] [Abstract][Full Text] [Related]
3. Return of the morning sickness pill. Could Bendectin be coming back to market?
AWHONN Lifelines; 2001; 5(1):22-3. PubMed ID: 11941692
[No Abstract] [Full Text] [Related]
4. Bendectin/diclectin for morning sickness: a Canadian follow-up of an American tragedy.
Ornstein M; Einarson A; Koren G
Reprod Toxicol; 1995; 9(1):1-6. PubMed ID: 8520127
[No Abstract] [Full Text] [Related]
5. 8-Way Randomized Controlled Trial of Doxylamine, Pyridoxine and Dicyclomine for Nausea and Vomiting during Pregnancy: Restoration of Unpublished Information.
Zhang R; Persaud N
PLoS One; 2017; 12(1):e0167609. PubMed ID: 28052111
[TBL] [Abstract][Full Text] [Related]
6. Bendectin and birth defects: hopefully, the final chapter.
Brent R
Birth Defects Res A Clin Mol Teratol; 2003 Feb; 67(2):79-87. PubMed ID: 12769503
[No Abstract] [Full Text] [Related]
7. Safety of drug therapy for nausea and vomiting of pregnancy.
Huff PS
J Fam Pract; 1980 Nov; 11(6):969-70. PubMed ID: 7005391
[No Abstract] [Full Text] [Related]
8. Safety and efficacy of antiemetics used to treat nausea and vomiting in pregnancy.
Leathem AM
Clin Pharm; 1986 Aug; 5(8):660-8. PubMed ID: 2874910
[TBL] [Abstract][Full Text] [Related]
9. Bendectin: a case of mourning sickness.
Hays DP
Drug Intell Clin Pharm; 1983 Nov; 17(11):826-7. PubMed ID: 6641507
[No Abstract] [Full Text] [Related]
10. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP).
Magee LA; Mazzotta P; Koren G
Am J Obstet Gynecol; 2002 May; 186(5 Suppl Understanding):S256-61. PubMed ID: 12011897
[TBL] [Abstract][Full Text] [Related]
11. Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial.
Koren G; Clark S; Hankins GD; Caritis SN; Umans JG; Miodovnik M; Mattison DR; Matok I
BMC Pregnancy Childbirth; 2015 Mar; 15():59. PubMed ID: 25884778
[TBL] [Abstract][Full Text] [Related]
12. Attitudes, management and consequences of nausea and vomiting of pregnancy in the United States and Canada.
Mazzotta P; Maltepe C; Navioz Y; Magee LA; Koren G
Int J Gynaecol Obstet; 2000 Sep; 70(3):359-65. PubMed ID: 10967171
[TBL] [Abstract][Full Text] [Related]
13. The innocent bystander. Doxylamine/dicyclomine/pyridoxine and congenital limb defects.
McCredie J; Kricker A; Elliott J; Forrest J
Med J Aust; 1984 Apr; 140(9):525-7. PubMed ID: 6708895
[TBL] [Abstract][Full Text] [Related]
14. Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies.
McKeigue PM; Lamm SH; Linn S; Kutcher JS
Teratology; 1994 Jul; 50(1):27-37. PubMed ID: 7974252
[TBL] [Abstract][Full Text] [Related]
15. Is Bendectin a teratogen?
Cordero JF; Oakley GP; Greenberg F; James LM
JAMA; 1981 Jun; 245(22):2307-10. PubMed ID: 7230458
[TBL] [Abstract][Full Text] [Related]
16. Measuring drug effectiveness by default: the case of Bendectin.
Neutel CI; Johansen HL
Can J Public Health; 1995; 86(1):66-70. PubMed ID: 7728721
[TBL] [Abstract][Full Text] [Related]
17. A new pharmacologic treatment for nausea and vomiting of pregnancy.
Fantasia HC
Nurs Womens Health; 2014; 18(1):73-77. PubMed ID: 24548499
[TBL] [Abstract][Full Text] [Related]
18. Congenital deformities associated with Bendectin.
Can Med Assoc J; 1977 Oct; 117(7):721-2. PubMed ID: 907941
[No Abstract] [Full Text] [Related]
19. A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy.
Mazzotta P; Magee LA
Drugs; 2000 Apr; 59(4):781-800. PubMed ID: 10804035
[TBL] [Abstract][Full Text] [Related]
20. New evidence for concern over the risk of birth defects from medications for nausea and vomitting of pregnancy.
Bérard A; Sheehy O; Gorgui J; Zhao JP; Soares de Moura C; Bernatsky S
J Clin Epidemiol; 2019 Dec; 116():39-48. PubMed ID: 31352006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
